About Tahoe Ventures
Tahoe Ventures is a venture capital firm founded in 2014. It is primarily based out of Suzhou, China. As of Feb 2023, Tahoe Ventures has invested in 17 companies. It primarily invests in Angel round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Angel round of Conjustar Overall, Tahoe Ventures portfolio has seen 2 IPOs, namely Juhe and Suzhou Kema Material Technology. A lot of funds co-invest with Tahoe Ventures, with names like JD.com sharing a substantial percentage of its portfolio. Tahoe Ventures has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Angel, Series A & 2 more
Portfolio IPOs
Portfolio Soonicorns
Tahoe Ventures' List of Top Investments
Tahoe Ventures has a portfolio of 17 companies. Their most notable investmentis in Forssmann MedicalTheir portfolio spans across China and United States. They have invested in Life Sciences, Enterprise Applications, HealthTech and 9 other sectors, across stages such as Angel, Series A and 2 more. Here is the list of top investments by Tahoe Ventures:
1. Juhe
Juhe is an aggregated cloud based data and a service platform which provides various types of raw data API for mobile developers, such as LBS data, wifi hotspots, gas stations, etc. Claims to have raised two rounds of funding
Key facts about Juhe
- Founded Year: 2006
- Location: Suzhou (China)
- Stage: Public
- Total Funding till date: $88.1M
- Employee Count: 20 as on Sep 30, 2026
- Investors: JD.com, China Media Capital and 4 Others
- Latest Funding Round: Series C, Dec 09, 2016, $*****
- Highlight: Public
Developer of an artificial heart valve and catheter implantation system. The device is used in heart valve replacement surgery without surgical sutures and cardiopulmonary bypass.
Key facts about Shanghai New Pulse Medical Technology
3. SceneRay
Developer of a portfolio of Neuromodulation devices. The company’s products include a deep brain stimulation system that includes implantable neuro-stimulator, extensions, patient controllers, accessories, leads, clinician programmers, and test neuro-stimulator. It also develops spinal cord stimulation and sacral nerve stimulation systems. Its deep brain stimulators have applications in the treatment of Parkinson's disease, Movement disorders, and Degenerative brain diseases, and its spinal cord and sacral nerve stimulators have applications in neuropathic pain management.
Key facts about SceneRay
- Founded Year: 2011
- Location: Suzhou (China)
- Stage: Series D
- Total Funding till date: $62.6M
- Employee Count: 22 as on Sep 30, 2026
- Investors: SBCVC, Shanghai STVC Group and 9 Others
- Latest Funding Round: Series D, Feb 16, 2022, $*****
- Highlight: Editors' Pick
4. Conjustar
Developer of drug conjugates for the treatment of cancer. The company is developing miniaturized drug conjugates such as peptide, nanobody drug conjugates, and PDC to conquer solid tumors.
Key facts about Conjustar
- Founded Year: 2022
- Location: Shanghai (China)
- Stage: Seed
- Total Funding till date: $27.8M
- Employee Count: 1 as on Aug 31, 2026
- Investors: Fosun Pharmaceutical, Tahoe Ventures and 4 Others
- Latest Funding Round: Seed, Jan 31, 2024, $*****
- Highlight: Editors' Pick
Forssmann Medical has developed interventional devices (projection infrared angiography system, wireless pressure pump, a guide wire for intracranial vessels), diagnostic devices (wireless blood flow reserve fraction micro-guidewire, intravascular optical tomography), and treatment series (single use saphenous vein extraction device, vertebral artery stent, inferior vena cava filter, intracranial mesh stent).
Key facts about Forssmann Medical
- Founded Year: 2014
- Location: Nanjing (China)
- Stage: Series A
- Employee Count: 8 as on Sep 30, 2026
- Investors: SAIF Partners, Ennovation Ventures and 2 Others
- Latest Funding Round: Series A, Oct 09, 2018, $*****
Tahoe Ventures' Year-on-Year Investment Trends
Tahoe Ventures has invested in 17 companies over the last 11 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Conjustar.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 1 | 0 | 1 |
2022 | 0 | 0 | 0 |
2021 | 1 | 0 | 1 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
Tahoe Ventures' Investments by Stage
Tahoe Ventures has made 1 investment in Angel stage with an average round size of $7.98M, 1 investment in Series A stage, 1 investment in Series B stage with an average round size of $34.3M and 1 investment in Series D stage with an average round size of $15.4M.Stage of entry | No. of Investments |
|---|---|
Angel | 1 |
Series A | 1 |
Series B | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Tahoe Ventures' Investments by Sector
Tahoe Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Enterprise Infrastructure, HealthTech and Healthcare. Notably, it has invested in 8 Enterprise (B2B) companies, 8 Tech companies, 4 Tech hardware companies and at least 2 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Enterprise Applications | 1 |
Enterprise Infrastructure | 1 |
HealthTech | 1 |
Healthcare | 1 |
Note: We have considered here, only first round of investments
Tahoe Ventures' Investments by Geography
Tahoe Ventures has made most investments in China (4).Tahoe Ventures' recent investments
Tahoe Ventures has not made any investment in 2026 so far.Here are the most recent investments by Tahoe Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 23, 2023 | China | Angel | 7272 | [+1] | |
Apr 21, 2021 | China | Series D | 7430 | [+1] | |
Oct 09, 2018 | China | Series A | 8223 | ||
Nov 2015 | China | Series B | 8501 | [+2] |
IPOs and Publicly Listed companies in Tahoe Ventures' Portfolio
2 of Tahoe Ventures' portfolio companies have become public. Suzhou Kema Material Technology got listed on the Shenzhen Stock Exchange (SZSE), in Aug 2024 at marketcap of $487M and Juhe got listed on the Hong Kong Exchanges (HKG) at marketcap of $535M.Here are Tahoe Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 16, 2024 | - | - | 7346 | |
Jun 28, 2024 | Nov 2015 | Series B | 4140 |
Team profile of Tahoe Ventures
Tahoe Ventures has a team of 1 member located in United States. Tahoe Ventures' team does not sit on the board of any company as of now.Co-investors of Tahoe Ventures
Over the past 11 years, 14 investors have co-invested in Tahoe Ventures's portfolio companies. This includes funds and angels.
- Invested before Tahoe Ventures: GeekFounders and Fosun Health Capital have invested in rounds before Tahoe Ventures. There is 1 company where GeekFounders has invested before Tahoe Ventures and 1 company where Fosun Health Capital has invested before Tahoe Ventures.
- Top Co-investors of Tahoe Ventures: 7 investors entered a company along with Tahoe Ventures. These include investors like JD.com (1 company).
- Invested after Tahoe Ventures: A total of 5 investors have invested in Tahoe Ventures's portfolio after their investments. Top Investors include Sequoia Capital China (1 company), Hillhouse Ventures (1 company) and Fosun Pharmaceutical (1 company).
